Literature DB >> 19241483

Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells.

Richard G Ruddell1, Diem Hoang-Le, Joanne M Barwood, Paul S Rutherford, Terrance J Piva, Dianne J Watters, Paolo Santambrogio, Paolo Arosio, Grant A Ramm.   

Abstract

UNLABELLED: Circulating ferritin levels reflect body iron stores and are elevated with inflammation in chronic liver injury. H-ferritin exhibits a number of extrahepatic immunomodulatory properties, although its role in hepatic inflammation and fibrogenesis is unknown. Hepatic stellate cells respond to liver injury through production of proinflammatory mediators that drive fibrogenesis. A specific receptor for ferritin has been demonstrated on activated hepatic stellate cells, although its identity and its role in stellate cell activation is unclear. We propose that ferritin acts as a cytokine regulating proinflammatory function via nuclear factor kappaB (NF-kappaB)-regulated signaling in hepatic stellate cell biology. Hepatic stellate cells were treated with tissue ferritin and iron-free apoferritin, recombinant H-ferritins and L-ferritins, to assess the role of ferritin versus ferritin-bound iron in the production of proinflammatory mediators of fibrogenesis, and to determine whether signaling pathways act via a proposed H-ferritin endocytosis receptor, T cell immunoglobulin-domain and mucin-domain 2 (Tim-2). This study demonstrated that ferritin activates an iron-independent signaling cascade, involving Tim-2 independent phosphoinositide 3 (PI3)-kinase phosphorylation, protein kinase C zeta (PKCzeta) and p44/p42-mitogen-activated protein kinase, resulting in p50/p65-NF-kappaB activation and markedly enhanced expression of hepatic proinflammatory mediators interleukin-1beta (IL-1beta), inducible nitric oxide synthase (iNOS), regulated on activation normal T cell expressed and secreted (RANTES), inhibitor of kappa Balpha (IkappaBalpha), and intercellular adhesion molecule 1 (ICAM1).
CONCLUSIONS: This study has defined the role of ferritin as a proinflammatory mediator of hepatic stellate cell biology acting through the NF-kappaB signaling pathway, and suggests a potential role in the inflammatory processes associated with hepatic fibrogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19241483      PMCID: PMC2701483          DOI: 10.1002/hep.22716

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

1.  Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells.

Authors:  D Moss; S Fargion; A L Fracanzani; S Levi; M D Cappellini; P Arosio; L W Powell; J W Halliday
Journal:  J Inorg Biochem       Date:  1992 Aug 15-Sep       Impact factor: 4.155

Review 2.  Ferritin.

Authors:  M Worwood
Journal:  Blood Rev       Date:  1990-12       Impact factor: 8.250

3.  Identification and characterization of the hepatic stellate cell transferrin receptor.

Authors:  Kim R Bridle; Darrell H G Crawford; Grant A Ramm
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.

Authors:  Paulo S Ribeiro; Helena Cortez-Pinto; Susana Solá; Rui E Castro; Rita M Ramalho; Amélia Baptista; Miguel C Moura; Maria E Camilo; Cecília M P Rodrigues
Journal:  Am J Gastroenterol       Date:  2004-09       Impact factor: 10.864

5.  Screening for hemochromatosis by measuring ferritin levels: a more effective approach.

Authors:  Jill Waalen; Vincent J Felitti; Terri Gelbart; Ernest Beutler
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

Review 6.  Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions.

Authors:  Takaaki Hirai; Kazuhiro Chida
Journal:  J Biochem       Date:  2003-01       Impact factor: 3.387

Review 7.  Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.

Authors:  Ahmed M Elsharkawy; Derek A Mann
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

8.  Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor.

Authors:  Xiaoling Yuan; Yuwen Cong; Jing Hao; Yajun Shan; Zhenhu Zhao; Shengqi Wang; Jiapei Chen
Journal:  J Mol Biol       Date:  2004-05-21       Impact factor: 5.469

9.  Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration.

Authors:  Robert F Schwabe; Ramon Bataller; David A Brenner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-06-26       Impact factor: 4.052

10.  Activation of nuclear factor kappa B (NF-kappaB) by connective tissue growth factor (CCN2) is involved in sustaining the survival of primary rat hepatic stellate cells.

Authors:  Runping Gao; David R Brigstock
Journal:  Cell Commun Signal       Date:  2005-11-22       Impact factor: 5.712

View more
  80 in total

1.  Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging.

Authors:  Emanuela Messa; Sonia Carturan; Chiara Maffè; Marisa Pautasso; Enrico Bracco; Antonella Roetto; Francesca Messa; Francesca Arruga; Ilaria Defilippi; Valentina Rosso; Chiara Zanone; Antonia Rotolo; Elisabetta Greco; Rosa M Pellegrino; Daniele Alberti; Giuseppe Saglio; Daniela Cilloni
Journal:  Haematologica       Date:  2010-06-09       Impact factor: 9.941

2.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

3.  Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Kris V Kowdley; Patricia Belt; Laura A Wilson; Matthew M Yeh; Brent A Neuschwander-Tetri; Naga Chalasani; Arun J Sanyal; James E Nelson
Journal:  Hepatology       Date:  2011-12-06       Impact factor: 17.425

4.  The CD68(+)/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis.

Authors:  P Ruscitti; F Ciccia; P Cipriani; G Guggino; P Di Benedetto; A Rizzo; V Liakouli; O Berardicurti; F Carubbi; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2015-12-08       Impact factor: 4.330

Review 5.  Liver inflammation and fibrosis.

Authors:  Yukinori Koyama; David A Brenner
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

6.  Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors.

Authors:  Tingting Du; Gang Yuan; Xinrong Zhou; Xingxing Sun
Journal:  Ann Med       Date:  2016-01-13       Impact factor: 4.709

7.  Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocytic lymphohistiocytosis syndrome*.

Authors:  Dennis W Simon; Rajesh Aneja; Joseph A Carcillo; E Scott Halstead
Journal:  Pediatr Crit Care Med       Date:  2014-06       Impact factor: 3.624

8.  Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells.

Authors:  David L Schonberg; Tyler E Miller; Qiulian Wu; William A Flavahan; Nupur K Das; James S Hale; Christopher G Hubert; Stephen C Mack; Awad M Jarrar; Robert T Karl; Ann Mari Rosager; Anne M Nixon; Paul J Tesar; Petra Hamerlik; Bjarne W Kristensen; Craig Horbinski; James R Connor; Paul L Fox; Justin D Lathia; Jeremy N Rich
Journal:  Cancer Cell       Date:  2015-10-12       Impact factor: 31.743

9.  How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis.

Authors:  Joseph A Carcillo; Dennis W Simon; Bradley S Podd
Journal:  Pediatr Crit Care Med       Date:  2015-07       Impact factor: 3.624

Review 10.  Iron and cancer: more ore to be mined.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Nat Rev Cancer       Date:  2013-04-18       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.